Full text is available at the source.
Abstract
The association between initiating a GLP-1 receptor agonist and thyroid disorders is uncertain.
- Evaluated the effects of starting a GLP-1 receptor agonist versus a DPP-4 inhibitor.
- Investigated the occurrence of newly recorded autoimmune thyroiditis and other thyroid outcomes.
- Findings may provide insight into the safety profile of GLP-1 receptor agonists concerning thyroid health.
Simplified